Seek Laboratories, Inc.

Salt Lake City, UT Doing business as Seek Labs

UEI
Y1HWF7CW2CB9
CAGE
08A14
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
350 W 800 N #220, Salt Lake City, UT 84103, USA
Website
seeklabs.com
Founded
2017
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
SIC code
96 Administration of Economic Programs
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

SBA capabilities narrative

Seek Labs' disease response platform is designed to compress the threat-to-decision timeline, preserving optionality and enabling stage-gated development of countermeasure pathways. The platform is built around two integrated components: BioSeeker, an AI-driven genomic intelligence engine that continuously analyzes global viral sequence data across hundreds of pathogens and millions of strains to identify functionally constrained regions that are essential to pathogen survival; and PTAP (Programmable Target Ablation Platform), a programmable CRISPR-based therapeutic modality that uses this genomic intelligence to disrupt those conserved targets at the level of pathogenic DNA or RNA. Together, they translate pathogen sequence intelligence into structured countermeasure design and architecture that supports countermeasure optionality, accelerates decision cycles, and strengthens resilience against emerging and engineered biological threats.

Quick answers

Is Seek Laboratories, Inc. registered in SAM.gov?

Yes. Seek Laboratories, Inc.'s SAM.gov registration is active through March 17, 2027.

What is Seek Laboratories, Inc.'s most recent federal award?

Seek Laboratories, Inc.'s most recent federal grant award is The highly pathogenic avian influenza (hpai) virus a/goose/guangdong/1/96 H5N1 (GS/GD) lineage has spread worldwide… (AP26VSSP0000C044), from Animal and Plant Health Inspection Service, on February 2, 2026.

On GovTribe

See Seek Laboratories, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors